These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20507847)

  • 1. Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA2DS2-VASc risk stratification scores.
    Pamukcu B; Lip GY; Lane DA
    Age Ageing; 2010 Sep; 39(5):533-5. PubMed ID: 20507847
    [No Abstract]   [Full Text] [Related]  

  • 2. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
    Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
    Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stratification with CHA2DS2-VASc score is better than CHADS2 score in reducing ischemic stroke risk in patients with atrial fibrillation.
    Pieri A; Lopes TO; Gabbai AA
    Int J Stroke; 2011 Oct; 6(5):466. PubMed ID: 21951414
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for antithrombotic therapy in atrial fibrillation: understanding the reasons for non-adherence and moving forwards with simplifying risk stratification for stroke and bleeding.
    Fauchier L; Lip GY
    Europace; 2010 Jun; 12(6):761-3. PubMed ID: 20388635
    [No Abstract]   [Full Text] [Related]  

  • 5. The assessment of stroke and bleeding risk in atrial fibrillation: where are we now?
    Pamukcu B; Lane DA; Lip GY
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1703-10. PubMed ID: 21108552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving stroke risk stratification in atrial fibrillation.
    Lip GY; Halperin JL
    Am J Med; 2010 Jun; 123(6):484-8. PubMed ID: 20569748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CHADS₂versus the new CHA2DS2-VASc scoring systems for guiding antithrombotic treatment of patients with atrial fibrillation: review of the literature and recommendations for use.
    Odum LE; Cochran KA; Aistrope DS; Snella KA
    Pharmacotherapy; 2012 Mar; 32(3):285-96. PubMed ID: 22392459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post myocardial infarction and atrial fibrillation: Thromboprophylaxis and risk stratification using the CHA2DS2-VASc score.
    Lau YC; Lip GY
    Cardiol J; 2014; 21(5):451-3. PubMed ID: 25472850
    [No Abstract]   [Full Text] [Related]  

  • 9. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R; Capucci A; Lip GY; Olsson SB; Prins MH; Nieman FH; López-Sendón J; Vardas PE; Aliot E; Santini M; Crijns HJ;
    Eur Heart J; 2006 Dec; 27(24):3018-26. PubMed ID: 16731536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice.
    Lip GY
    Thromb Haemost; 2010 Apr; 103(4):683-5. PubMed ID: 20135056
    [No Abstract]   [Full Text] [Related]  

  • 11. Antithrombotic therapies for stroke prevention in atrial fibrillation.
    Hart RG
    Adv Neurol; 2003; 92():249-56. PubMed ID: 12760190
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk stratification in the management of atrial fibrillation in the community.
    Fahey T; Rimmer J; Godfrey P
    Br J Gen Pract; 1999 Apr; 49(441):295-6. PubMed ID: 10736908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ;
    Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The challenge of preventing stroke in elderly patients with atrial fibrillation.
    Boriani G; Biffi M; Diemberger I; Ziacchi M; Martignani C
    J Cardiovasc Electrophysiol; 2011 Jan; 22(1):31-3. PubMed ID: 20812926
    [No Abstract]   [Full Text] [Related]  

  • 15. [2010 European guidelines for antithrombotic therapy in patients with atrial fibrillation and new risk score for the assessment of the risk of bleeding].
    Melon P; Lancellotti P
    Rev Med Liege; 2010 Oct; 65(10):580-2. PubMed ID: 21128364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic management of atrial fibrillation for stroke prevention in older people.
    Tong DC; Albers GW
    Clin Geriatr Med; 1999 Nov; 15(4):645-62. PubMed ID: 10499928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation for atrial fibrillation patients with CHADS score of 1.
    Lane DA; Lip GY
    J Cardiovasc Electrophysiol; 2010 May; 21(5):508-10. PubMed ID: 20082649
    [No Abstract]   [Full Text] [Related]  

  • 18. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Incidence and risk factors of stroke in patients with nonvalvular atrial fibrillation in Haikou].
    Zeng M; Wu ZY; Zheng Y; Chen J; Feng GQ; Fu XH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):905-8. PubMed ID: 19950611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confronting atrial fibrillation in the elderly: stroke risk stratification and emerging antithrombotic therapies.
    Strong SH; Halperin JL
    Geriatrics; 2007 Mar; 62(3):22-7. PubMed ID: 17346095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.